Skip to main content

MoneyWorks4Me

Orchid Chemicals & Pharmaceuticals informs about Outcome of Board Meeting

15 Jul 2014 Evaluate

Orchid Chemicals & Pharmaceuticals has informed that the Board of Directors of the Company at its meeting held on July 14, 2014, has approved the issue of shares to Promoters on a preferential basis pursuant to the conditions of CDR package sanctioned to the Company by Corporate Debt Restructuring Cell.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1762.95
Dr. Reddys Labs. 1338.50
Cipla 1357.00
Lupin 1998.00
Zydus Lifesciences 1186.00
View more..